Branched synthetic peptide constructs mimic cellular binding and efflux of apolipoprotein AI in reconstituted high density lipoproteins

Atherosclerosis

Volumn 141, Issue 2, 1998, Pages 227-235

  Nion, Stéphane ^a   Demoor, Ludovic ^a   Boutillon, Christophe ^a   Luchoomun, Jayraz ^a   Vanloo, Berlinda ^b   Fievet, Catherine ^a   Castro, Graciela ^a   Rosseneu, Maryvonne ^b   Fruchart, Jean Charles ^a   Tartar, André ^a   Clavey, Véronique ^a  

^a INSTITUT PASTEUR DE LILLE   (France)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

Apolipoprotein AI; Branched peptide; Cell binding; Cholesterol efflux; LCAT; Reconstituted high density lipoprotein

Indexed keywords

APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN;

ALPHA HELIX; ARTICLE; CELL INTERACTION; CHOLESTEROL TRANSPORT; COMPETITIVE INHIBITION; COMPLEX FORMATION; COVALENT BOND; DRUG RECEPTOR BINDING; ENZYME RECONSTITUTION; HUMAN; HUMAN CELL; LIPOPROTEIN SYNTHESIS; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; RECEPTOR AFFINITY;

ANIMALS; APOLIPOPROTEIN A-I; CHOLESTEROL; HELA CELLS; HUMANS; LIPOPROTEINS, HDL; LIVER NEOPLASMS, EXPERIMENTAL; PEPTIDES; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; PROTEIN CONFORMATION; RATS; TUMOR CELLS, CULTURED;

EID: 18544402516     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00176-2     Document Type: Article

References (38)

1. Forte TM, McCall MR The role of apolipoprotein A-I-containing lipoproteins in atherosclerosis. Curr Opin Lipidol. 5:1994;354-364.
2. Rubin EM, Krauss RM, Spangler EA, Verstuyft JG, Clift SM Inhibition of early atherogenesis in transgenic mice by human apolipoprotein A-I. Nature. 353:1991;265-267.
3. Breslow JL, Plump A, Dammerman M New mouse models of lipoprotein disorders and atherosclerosis. Fuster V, Ross R, Topol EJ Atherosclerosis and Coronary Artery Disease. 1996;363-378 Lippincott-Raven, Philadelphia, PA.
4. Mahlberg FH, Rothblat GH Cellular cholesterol efflux: role of cell membrane kinetic pools and interaction with apolipoproteins AI, AII, and Cs. J Biol Chem. 267:1992;4541-4550.
5. Luchoomun J, Theret N, Clavey V, Duchateau P, Rosseneu M, Brasseur R, Denefle P, Fruchart JC, Castro GR Structural domain of apolipoprotein A-I involved in its interaction with cells. Biochim Biophys Acta. 1212:1994;319-326.
6. Banka CL, Black AS, Curtiss LK Localization of an apolipoprotein A-I epitope critical for lipoprotein-mediated cholesterol efflux from monocytic cells. J Biol Chem. 269:1994;10 288-10 297.
7. Fielding PE, Kawano M, Catapano AL, Zoppo A, Marcovina S, Fielding CJ Unique epitope of apolipoprotein A-I expressed in pre-β-1 high-density lipoprotein and its role in the catalyzed efflux of cellular cholesterol. Biochemistry. 33:1994;6981-6985.
8. Palgunachari MN, Mishra VK, Lund-Katz S, Phillips MC, Adeyeye SO, Alluri S, Anantharamaiah GM, Segrest JP Only the two end helices of eight tandem amphipathic helical domains of human apo A-I have significant lipid affinity. Implications for HDL assembly. Arterioscler Thromb Vasc Biol. 161:1996;328-338.
9. Fielding CJ, Shore VG, Fielding PE A protein cofactor of lecithin: cholesterol acyl transferase. Biochim Biophys Res Commun. 46:1972;1493-1498.
10. Jonas A, Zorich NL, Kézdi KE, Trick WE Reaction of discoidal complexes of apolipoprotein A-I and various phosphatidylcholines with lecithin cholesterol acyltransferase. J Biol Chem. 262:1987;4818-4824.
11. Pieters MN, Castro GR, Shouten D, Duchateau P, Fruchart JC, Van Berkel TJ Cholesterol esters selectively delivered in vivo by high-density-lipoprotein subclass Lp-AI to rat liver are processed faster into bile acids than are LpA-I/LpA-II-derived cholesteryl esters. Biochem J. 292:1993;819-823.
12. Acton S, Rigotti A, Landschulz KT, Xu S, Hobbs HH, Krieger M Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science. 271:1996;518-520.
13. Brasseur R, De Meutter J, Vanloo B, Goormaghtigh E, Ruysschaert JM, Rosseneu M Mode of assembly of amphipathic helical segments in model high density lipoproteins. Biochim Biophys Acta. 1043:1990;245-252.
14. Pownall HJ, Massey JB, Sparrow JT, Gotto AM Jr. Lipid-protein interactions and lipoprotein reassembly. Gotto AM Plasma Lipoproteins. 1987;95-127 Elsevier, Amsterdam.
15. Yokoyama S, Fukushima D, Kupferberg JP, Kézdy FJ, Kaiser ET The mechanism of activation of lecithin:cholesterol acyl transferase by apolipoprotein A-I and an amphiphilic peptide. J Biol Chem. 255:1980;7333-7339.
16. Fukushima D, Yokoyama S, Kroon DJ, Kezdy FJ, Kaiser ET Chain length-function correlation of amphiphilic peptides: synthesis and surface properties of a tetratetracontapeptide segment of apolipoprotein A-I. J Biol Chem. 255:1980;10 651-10 657.
17. Vanloo B, Demoor L, Boutillon C, Lins L, Baert J, Fruchart JC, Tartar A, Rosseneu M Association of synthetic peptide fragments of human apolipoprotein A-I with phospholipids. J Lipid Res. 36:1995;1686-1696.
18. Demoor L, Boutillon C, Fiévet C, Vanloo B, Baert J, Rosseneu M, Fruchart JC, Tartar A Branched synthetic constructs that mimic the physico-chemical properties of apolipoprotein AI in reconstituted high-density lipoproteins. Eur J Biochem. 239:1996;74-84.
19. Brasseur R, Lins L, Vanloo B, Ruysschaert JM, Rosseneu M Molecular modeling of the amphipathic helices of the plasma apolipoproteins. Proteins Struct Funct Genet. 13:1991;246-257.
20. 2 and E from human plasma. J Chromatogr. 414:1987;35-45.
21. Bonomo EA, Swaney JB A rapid method for the synthesis of protein-lipid complexes using adsorption chromatography. J Lipid Res. 29:1988;380-384.
22. Lowry OH, Rosebrough NJ, Farr AL, Randal RJ Protein measurement with the Folin phenol reagent. J Biol Chem. 193:1951;265-275.
23. Bilheimer DW, Eisenberg S, Levy RI The metabolism of low density lipoproteins. Preliminary in vitro and in vivo observations. Biochim Biophys Acta. 260:1972;212-221.
24. Marcel YL, Provost PR, Koa H, Raffai E, Vu Dac N, Fruchart JC, Rassart E The epitopes of apolipoprotein A-I define distinct structural domains including a mobile middle region. J Biol Chem. 266:1991;3644-3653.
25. Calabresi L, Meng QH, Castro GR, Marcel YL Apolipoprotein A-I conformation in discoidal particles: evidence for alternate structures. Biochemistry. 32:1993;6477-6484.
26. McConahey PJ, Dixon FJ Radioiodination of proteins by the use of the chloramine T method. Methods Enzymol. 70:1980;210-213.
27. De La Llera Moya M, Atger V, Paul JL, Fournier N, Moatti N, Giral P, Friday KE, Rothblat GH A cell culture system for screening human serum for ability to promote cellular cholesterol efflux: relationships between serum components and efflux, esterification and transfer. Arterioscler Thromb. 14:1994;1056-1065.
28. Vercaemst R, Union A, Rosseneu M Separation and quantitation of free cholesterol and cholesteryl esters in a macrophage cell line by high performance liquid chromatography. J Chromatogr. 494:1989;43-52.
29. Peelman F, Vinaimont N, Verhee A, Vanloo B, Verschelde JL, Labeur C, Séguret-Macé S, Duverger N, Hutchinson G, Vandekerckhove J, Tavernier J, Rosseneu M A proposed architecture for lecithin cholesterol acyl transferase. Identification of the catalytic triad and molecular modeling of LCAT. Prot Sci. 7:1998;587-599.
30. Vanloo B, Taveirne J, Baert G, Lorent G, Vercaemst R, Lins L, Ruysschaert JM, Rosseneu M Activation of lecithin cholesterol acyl transferase (LCAT) by the CNBr fragments of human apo AI and conversion of the discoidal complexes into spherical particles. Biochim Biophys Acta. 1128:1992;258-266.
31. Phillips MC, McLean LR, Stoudt GW, Rothblat GH Mechanism of cholesterol efflux from cells. Atherosclerosis. 36:1980;409-422.
32. Lagrost L, Dengremont C, Athias A, De Geitere C, Fruchart JC, Lallemant C, Gambert P, Castro G Modulation of cholesterol efflux from Fu5AH hepatoma cells by the apolipoprotein content of high density lipoprotei particles. J Biol Chem. 270:1995;13 004-13 009.
33. Davidson WS, Rodrigueza WV, Lund-Katz S, Jonhson WJ, Rothblat GH, Phillips MC Effects of acceptor particle size on the efflux of cellular free cholesterol. J Biol Chem. 270:1995;17 106-17 113.
34. 165→Arg). J Biol Chem. 268:1993;2616-2622.
35. Allan CM, Fidge NH, Kanellos J Antibodies to the carboxyl terminus of human apolipoprotein AI. J Biol Chem. 267:1992;13 257-13 261.
36. Allan CM, Fidge NH, Kanellos J Monoclonal antibodies to human apolipoprotein AI: probing the putative receptor binding domain of apolipoprotein AI. Biochem J. 290:1993;449-455.
37. Barter PJ, Hopkins GJ, Gorjatschko L Lipoprotein substrates for plasma cholesterol esterification. Influence of particle size and composition of the high density lipoprotein subfraction 3. Atherosclerosis. 58:1985;97-107.
38. Hoelvoet P, Zhao Z, Vanloo B, Vos R, Derrider E, Dhoest A, Taveirne J, Brouwers E, Demarsin E, Engelborghs Y, Rosseneu M, Collen D, Brasseur R Phospholipid binding and lecithin:cholesterol acyltransferase activation properties of apolipoprotein A-I mutants. Biochemistry. 34:1995;13 334-13 342.